Clemens Seidel

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 556 citations · Full text

Hematological Malignancy, Neuro-oncology, Treatment Strategies +13

Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?

Christian Hartmann, Bettina Hentschel, Marcos Tatagiba et al. · Clinical Cancer Research · 2011 · 172 citations · Full text

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

Andrew B. Lassman, Stephanie L. Pugh, Tony J. C. Wang et al. · Neuro-Oncology · 2022 · 131 citations · Full text

Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)

Dagmar Beier, Martin Proescholdt, Christiane Reinert et al. · Neuro-Oncology · 2017 · 85 citations · Full text

Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma

Clemens Seidel, Nils Dörner, Matthias Osswald et al. · BMC Cancer · 2011 · 56 citations · Full text